Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zibotentan in Microvascular Angina
NCT04097314Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Oct 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zibotentan in microvascular angina (MVA), sponsored by NHS Greater Glasgow and Clyde. Started Oct 2019; status: completed.
02
Drugs
zibotentan
03
Conditions
microvascular angina (MVA)
Beyond the preview
Go deeper on NCT04097314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04097314.